MICHAELA JOHNSON: Open Payments
NPI 1407312549 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,975 in 115 payments from 20 companies in 2025. Trend: 2023 $1,483 · 2024 $2,032 · 2025 $1,975
Food & beverage: $1,975
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 26 | $364 |
| AstraZeneca Pharmaceuticals LP | 15 | $261 |
| ABBVIE INC. | 10 | $156 |
| Novo Nordisk Inc | 7 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $130 |
| Lilly USA, LLC | 11 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $130 |
| Otsuka America Pharmaceutical, Inc. | 6 | $114 |
| Exact Sciences Corporation | 5 | $90 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
Products named: NURTEC ODT, JARDIANCE, CAPLYTA, FARXIGA, REXULTI, VRAYLAR, MOUNJARO, BREZTRI.
Industry payments across IA — which companies pay providers there.
